Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

Stock Information for Acurx Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.